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Stim and Orai proteins comprise the molecular machinery of Ca2+
release-activated Ca2+ (CRAC) channels. As an approach toward un-
derstanding the gating of Orai1 channels, we investigated effects of
selected mutations at two conserved sites in the ﬁrst transmem-
brane segment (TM1): arginine 91 located near the cytosolic end
of TM1 and glycine 98 near the middle of TM1. Orai1 R91C, when
coexpressed with STIM1, was activated normally by Ca2+-store de-
pletion. Treatment with diamide, a thiol-oxidizing agent, induced
formation of disulﬁde bonds between R91C residues in adjacent
Orai1 subunits and rapidly blocked STIM1-operated Ca2+ current.
Diamide-induced blocking was reversed by disulﬁde bond-reducing
agents. These results indicate that R91 forms a very narrow part of
the conducting pore at the cytosolic side. Alanine replacement at
G98 prevented STIM1-induced channel activity. Interestingly, muta-
tion to aspartate (G98D) or proline (G98P) caused constitutive chan-
nel activation in a STIM1-independent manner. Both Orai1 G98
mutants formed a nonselective Ca2+-permeable conductance that
was relatively resistant to block by Gd3+. The double mutant
R91W/G98D was also constitutively active, overcoming the normal
inhibition of channel activity by tryptophan at the 91 position found
in some patients with severe combined immunodeﬁciency (SCID),
and the double mutant R91C/G98D was resistant to diamide block.
These data suggest that the channel pore is widened and ion selec-
tivity is altered by mutations at the G98 site that may perturb α-he-
lical structure. We propose distinct functional roles for G98 as
a gating hinge and R91 as part of the physical gate at the narrow
inner mouth of the channel.
store-operated Ca2+ entry | gating mechanism | Ca2+
Store-operated Ca
2+ entry (SOCE) leads to reﬁlling of Ca2+
content within the endoplasmic reticulum (ER) following
inositol trisphosphate-mediated Ca2+ release (1). In T lympho-
cytes and other hematopoietic cells, depletion of Ca2+ fromwithin
the ER Ca2+ store activates Ca2+ release-activated Ca2+ (CRAC)
channels and ampliﬁes cytosolic Ca2+ signaling following receptor
engagement, leading to changes in gene expression that regulate
immune responses (2, 3). STIM andOrai proteins were discovered
in RNA interference screens as the two essential components that
underlie CRAC channel function (4–8). The human genome
contains two STIM (STIM1 and STIM2) and three Orai (Orai1,
Orai2, and Orai3) genes. Orai1, with four transmembrane (TM)
segments in the plasma membrane (PM), is the CRAC channel
pore-forming subunit in T lymphocytes (4, 7–11), and STIM1 with
one TM segment serves as the ER Ca2+ sensor/activation subunit
that opens CRAC channels in the PM (5, 6, 12, 13).
The functional CRAC channel is unusual in having an extremely
low single-channel conductance and is highly selective for Ca2+
ions (14–16). Available evidence indicates that the channel con-
ducts as a tetramer of Orai1 subunits (17–21). Site-directed mu-
tagenesis conﬁrmed Drosophila Orai and human Orai1 as pore-
forming subunits by identifying conserved glutamate residues
near the extracellular side of TM1 of Orai (E180) or Orai1 (E106)
that confer Ca2+ selectivity on the STIM-operated Orai current
(9–11, 22). Mutations of STIM1 and Orai1 have been shown to
cause severe combined immunodeﬁciency (SCID) in human
patients (4, 23, 24). In particular, Orai1 R91, the site of the orig-
inally described SCIDmutation (4)—R91Wnear the cytosolic side
of the ﬁrst TM segment (TM1)—has been investigated by site-
speciﬁc mutagenesis (4, 19, 25).
Several studies have elucidated the chain of events that link
Ca2+ release from the ER to activation of CRAC channels in the
PM. Upon ER Ca2+-store depletion, STIM1 unbinds Ca2+ and
translocates to ER junctions adjacent to the PM, where a C-ter-
minal domain of STIM1 interacts with Orai1 cytosolic domains,
opening the Orai1 channel and causing Ca2+ inﬂux (26). Recent
studies using cysteine scanning combined with blocker accessibility
and disulﬁde cross-linking studies suggest an α-helical structure in
Orai1 TM1 (27, 28). Nevertheless, the molecular events following
STIM1–Orai1 interaction that lead to channel opening remain
elusive, and the gating determinants within Orai1 are undeﬁned.
In this study, we sought to explore elements within Orai1 that
control channel gating by biochemical and functional analysis of
Orai1 point mutants. We analyzed mutations of arginine 91 to
determine whether oxidation of R91C could form disulﬁde bonds
between adjacent Orai1 subunits and block channel function.
Furthermore, we explored mutations of Orai1 at the conserved
glycine residue in the middle of TM1 (G98) and found either
dominant-negative inhibition or robust spontaneous activation of
Orai1 proteins as functional channels (store- and STIM1-in-
dependent), depending on the amino acid substitution. Bio-
physical analysis indicated a distinct channel open state with
altered ion selectivity in spontaneously active G98 mutants. We
further analyzed double mutants bearing both inhibitory and ac-
tivating mutations at R91 and G98 sites, respectively, to determine
whether R91W or G98D effects are dominant. Our data suggest
that R91 forms a very narrow part of the conducting pore at the
cytosolic side of TM1, and that G98, in themiddle of TM1, is likely
to serve as a gating hinge of Orai1 channels.
Results
Bulky Hydrophobic Side Chains at R91 Inhibit Orai1 Channel Activity.
We initially screened several Orai1 R91 point mutants by Ca2+
Author contributions: S.L.Z., A.V.Y., J.H., and M.D.C. designed research; S.L.Z., A.V.Y.,
A.A., and H.Z. performed research; S.L.Z. and A.V.Y. analyzed data; and S.L.Z., A.V.Y.,
and M.D.C. wrote the paper.
The authors declare no conﬂict of interest.
1S.L.Z. and A.V.Y. contributed equally to this work.
2To whom correspondence may be addressed. E-mail: shenyuan.zhang@medicine.tamhsc.
edu or mcahalan@uci.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1114821108/-/DCSupplemental.
17838–17843 | PNAS | October 25, 2011 | vol. 108 | no. 43 www.pnas.org/cgi/doi/10.1073/pnas.1114821108
imaging in transfected HEK-293A cells. Expression levels and
PM localization of wild-type (WT) Myc-tagged Orai1 and Orai1
R91 mutants were similar, based upon immunoﬂuorescence (Fig.
S1) and Western blotting. In cells cotransfected with STIM1 and
WT Orai1, thapsigargin (TG) treatment produced elevation of
cytosolic Ca2+ concentrations ([Ca2+]i) to more than 800 nM
(863 ± 42 nM, n = 77 cells; Fig. 1A), much greater than the
endogenous SOCE in control cells transfected with green ﬂuo-
rescent protein (GFP) only (264 ± 15 nM, n = 81 cells; Fig.
S2A). In agreement with previous studies (4, 19, 25), substitution
with tryptophan at R91, namely the SCID mutation Orai1
R91W, inhibited Ca2+ entry to below the endogenous level
(124 ± 31 nM, n = 25 cells). Among other amino acid sub-
stitutions tested (Fig. 1A and Fig. S2), smaller amino acids such
as alanine, glycine, or cysteine all promoted Ca2+ inﬂux to levels
similar to wild-type (883 ± 89 nM, 21 cells for R91A; 628 ± 40
nM, 20 cells for R91G; 575 ± 56 nM, 26 cells for R91C).
Moreover, charge-conserving and even charge-reversing amino
acid substitutions also promoted Ca2+ entry (904 ± 127 nM, 15
cells for R91K; 1,037 ± 131 nM, 24 cells for R91D). However,
similar to R91W, substitution with leucine (R91L) did not sup-
port SOCE (250 ± 36 nM, 12 cells). These results are consistent
with previous studies (4, 25) showing that only bulky hydrophobic
amino acid substitutions at R91 inhibit Orai1 channel function.
R91C on Adjacent Subunits Can Form Disulﬁde Bonds, Blocking Orai1
Channel Activity. To test the idea that R91 residues on adjacent
subunits are sufﬁciently close together that a bulky hydrophobic
amino acid substitution could physically occlude the channel or
prevent opening, we tested for the ability of functional R91C
channels to form disulﬁde bonds. Intact HEK-293A cells ex-
pressing functional WT or R91C Orai1 were treated with di-
amide, an oxidant that catalyzes disulﬁde-bond formation between
nearby cysteine residues (Fig. 1B). Wild-type Orai1 proteins were
detected primarily as a monomer band, consistent with its pre-
dicted molecular weight (∼34 kDa) with or without diamide
treatment. We note that even without diamide treatment, there
was some residual level of Myc-Orai1 oligomers from both wild-
type and R91C mutants, most likely due to the higher-order stoi-
chiometry of Orai1 as membrane proteins with dimer or tetramer
structure in intact cells (18, 20, 29, 30), along with incomplete
dissociation during cell-lysate treatment. However, for R91C, di-
amide treatment caused the monomer band to disappear as a
strong band at higher molecular weight emerged, consistent with
covalent dimer formation. The dimers reverted to monomers
following incubation of cell lysates with dithiothreitol (DTT),
conﬁrming disulﬁde-bond formation. These results suggested that
cysteine residues at position 91 on adjacent subunits may come
close enough to form disulﬁde bridges.
To rule out the possibility that the R91C dimers were formed by
disulﬁde bonds between 91C and cysteine residues elsewhere
within Orai1, the three intrinsic cysteine residues were mutated to
serine to generate a cysteine-less Orai1 mutant (C-less Orai1). C-
less Orai1 functioned in Ca2+-imaging experiments exactly as wild-
type (Fig. 1A) and did not form diamide-induced dimers. Indeed,
we conﬁrmed as expected that the R91C mutant of C-less Orai1
also formed dimers when incubated with diamide (Fig. 1C).
Moreover, upon diamide treatment, the GFP-tagged WT Orai1
was present as a monomer of the expected molecular weight (∼61
kDa), whereas R91CGFP-Orai1 showed a strong dimer band with
a higher molecular weight (∼122 kDa; Fig. 1D). These results
exclude the possibility that the indicated Orai1 dimer band in Fig.
1B was not formed by R91C Orai1 homodimers but by disulﬁde
bonds between exogenous Orai1 and some endogenous proteins
similar in size to Orai1. Together, these data reinforce the con-
clusion that Cys residues at position 91 on adjacent Orai1 subunits
are sufﬁciently close to form disulﬁde linkages.
Functional effects of diamide treatment on Orai1 channel ac-
tivity were further examined by Ca2+ imaging and whole-cell
current recording. Application of 1–10 mM diamide inhibited TG-
evoked Ca2+ inﬂux through R91C Orai1, but had little effect on
WTOrai1 (Fig. 2A and B and Fig. S3). Diamide-induced blockage
of R91C Orai1 was quickly reversed by application of the reducing
agent DTT. These results demonstrate that disulﬁde-bond for-
mation between adjacent R91C sites blocks Orai1 channel activity.
Moreover, treatment with diamide during TG application also
nearly abolished Ca2+ inﬂux through R91C channels but not WT
Orai1 channels, indicating that Ca2+ inﬂux through the channel is
not required for the diamide block (Fig. 2 C and D and Fig. S3).
Again, treatment with DTT reversed the diamide block and re-
stored Ca2+ inﬂux through R91C channels, but had only a mild
effect on WT channels. Fig. 2 E and F shows the effect of diamide
on STIM1-induced R91C Orai1 whole-cell current activated by
passive store depletion during pipette dialysis with 12 mM 1,2-
bis(o-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid (BAPTA).
As expected, following the typical activation of CRAC-like cur-
rent, elevation of external Ca2+ increased the inwardly rectifying
current amplitudes. Following some current rundown (before
trace 1), diamide treatment (10 mM) rapidly blocked the current
(trace 2). Subsequent treatment with a reducing agent, bis(2-
mercaptoethyl)sulfone (BMS) (5 mM), partially restored the R91C
current (traces 3 and 4), consistent with a reduction of disulﬁde
bonds formed during diamide treatment. In cells cotransfected with
WTOrai1 plus STIM1, diamide partially suppressed the current by
32 ± 14% (n= 4); but unlike its effect on the R91C Orai1 current,
diamide block was completely reversible upon washout. Collec-
tively, our Ca2+-imaging and patch-clamp data indicate that di-
Fig. 1. Diamide treatment induces R91C to form homo-disulﬁde bonds. (A)
[Ca2+]i responses (mean ± SE) before and following store depletion by ad-
dition of 2 μM TG to HEK cells transfected with STIM1 + Myc-Orai1 (positive
control; n = 5 cells), STIM1 + R91WMyc-Orai1 (n = 8 cells), STIM1 + C-less Myc-
Orai1 (n = 4 cells), and STIM1 + R91C Myc-Orai1 (n = 10 cells). Data shown are
representative of at least three experiments with >15 cells for each condi-
tion. Vertical lines indicate the time of solution exchange. Ca0 indicates zero
free Ca2+; Ca2 indicates 2 mM Ca2+ (Table S1). (B) Representative Western
blotting (n = 4) of Myc-tagged WT Orai1 and R91C Orai1 from cells treated
without or with 10 mM diamide; total cell lysates were boiled either with or
without DTT (100 mM, 10 min at 70 °C). MW refers to molecular weight
markers (kDa). (C) Representative Western blotting of Myc-tagged C-less
Orai1 and C-less R91C Orai1 from cells treated with or without diamide and
DTT. (D) Representative anti-GFP Western blotting of cell lysates with
overexpressed GFP-Orai1 and R91C GFP-Orai1 proteins.
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amide treatment induces disulﬁde-bond formation in adjacent
Orai1 R91C subunits and blocks functional channel activity.
G98D and G98P Orai1 Form Spontaneously Active Ca2+ Channels in the
Absence of STIM1. In the middle of the predicted TM1 α-helix,
a conserved glycine residue (G98) is predicted to be located exactly
two α-helical turns from the R91 site. We hypothesize that glycine
could provide conformational ﬂexibility in TM1 to open Orai1
channels upon interaction with STIM1. A series of mutants with
alanine substitutions was generated around this 98 site; all were
well-expressed as examined by immunoﬂuorescence (Fig. S1) and
Western blotting, and were evaluated by Ca2+ imaging. Expression
of G98A Orai1 with STIM1 failed to exhibit channel activity,
suggesting an important role of the original Gly at this position.
Indeed, G98AOrai1 completely inhibited endogenous SOCE (Fig.
S4C; peak: 74 ± 16 nM, 18 cells; P < 0.0001 compared with peak of
control cells, as shown in Fig. S2A); this may indicate a dominant-
negative action by subunit assembly with endogenous WT Orai1
subunits. To further investigate the role of glycine at position 98, we
generated mutations that might perturb structure in TM1 by sub-
stitution with negatively charged aspartate. We also tested whether
the presence of a proline at position 98 may induce spontaneous
channel activity. Strikingly, G98D and G98P mutants each resulted
in constitutive Orai1 channel activation (Fig. 3 A and B). Even
when expressed alone, andwithout the requirement for TG-evoked
store depletion, G98D and G98POrai1 mutants caused a dramatic
elevation of resting [Ca2+]i compared with WT. The elevated
resting Ca2+ induced by both mutants was reduced by application
of 2-aminoethyl diphenylborinate (2-APB) or Gd3+. Possibly as
a result of the abnormally high cytosolic free Ca2+, most G98D-
and G98P-expressing cells were killed within 2 d after transfection.
Altered Open Channel Properties in Constitutively Active G98D and
G98P Orai1 Mutants. To permit detailed functional evaluation of
ion selectivity, we protected G98D-expressing cells from death by
treatment with 10 μM La3+ (SI Materials and Methods) and ana-
lyzed G98D Orai1 spontaneous channel activity (Fig. 3C). Unlike
the WT Orai1 mutant, neither G98D nor G98P required STIM1
coexpression to produce robust currents. In contrast to CRAC-like
inwardly rectifying current-voltage (I-V) curve with its character-
istic positive reversal potential, the current induced by G98D was
nearly linear, with a reversal potential close to 0 mV and an out-
ward component carried by Cs+ (Fig. 3D, black trace). Ion-sub-
stitution experiments, using choline to replace Na+ and varying
Fig. 2. R91C Orai1 channels are blocked by oxidation treatment. (A and B)
[Ca2+]i responses (±SE) before and following store depletion by addition of
2 μM TG. Effect of diamide (Dia) (1 mM) and following DTT (2 mM) application
on Ca2+ inﬂux in cells cotransfected with STIM1 and either WT Orai1 or R91C
Orai1 (n = 5 and 8 cells, respectively). (C and D) Pretreatment with diamide
(1 mM) has no effect on WT Orai1 but prevents Ca2+ inﬂux through R91C
Orai1 (n = 7 cells for each). DTT restores Ca2+ inﬂux through R91C channels.
(E) Representative result for block of R91C Orai1 CRAC current by diamide
treatment (10 mM, n = 13 cells); recovery upon BMS treatment (5 mM, n = 6
cells). Traces are leak-subtracted; the current at break-in was considered as
the leak. (F) Corresponding I-V curves for the time points indicated in E.
Fig. 3. G98 mutants form spontaneously activated Orai1 channels. (A) Rest-
ing [Ca2+]i in cells expressing WT Orai1 without STIM1 (n = 8 cells) or in cells
expressing G98D Orai1 (n = 7 cells). Representative data are shown; average
values include 46 ± 4 nM, 41 cells forWT Orai1; 260 ± 28 nM, 81 cells for G98D;
P< 0.0001 forWT comparedwith G98D; P < 0.0001 for Ca2 comparedwith Ca0
in 44 cells transfected with G98D. 2-APB application (50 μM). (B) Resting [Ca2+]i
in cells expressing G98P Orai1 (n = 8 cells); 190 ± 42 nM, 14 cells for G98P; P <
0.0001 for WT compared with G98P; P = 0.0032 for Ca2 compared with Ca0 in
14G98P cells. Gd3+ application (10 μM). (C) Time course of inward and outward
G98D Orai1 currents, measured at −120 and +100 mV, respectively. Currents
are representative of six experiments. ChoI, choline. (D) Corresponding I-V
relationships. Numbered traces and colors correspond to times indicated in C.
(E and F) Time course and I-V relationships of G98POrai1 currents. Currents are
representative of four experiments.
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external Ca2+ concentration, revealed a substantial inward Na+
current component (Fig. 3D, green trace), along with a small
component of inward Ca2+ current (Fig. 3D, magenta trace; data
summary in Fig. S5). The current sensitivity to block by Gd3+ was
considerably reduced compared with WT; the half-blocking con-
centration was 310 nM for G98D and 7 nM for WT Orai1 (Fig.
S6). Finally, by noise analysis, the large G98D monovalent cur-
rents reﬂect a greatly increased single-channel conductance of ∼9
pS for G98D Orai1 compared with <10 fS for STIM1-operated
Ca2+-selective WT Orai1 (Fig. S7).
To test whether a charged residue at G98 is required for
spontaneous nonselective currents, we evaluated proline sub-
stitution to disrupt the α-helical TM1 structure. G98P Orai1
constitutively active channels showed closely similar but not
identical biophysical properties to G98D (Fig. 3E). Resembling
G98D, the G98P Orai1 I-V relationship in normal Ringer solution
exhibited only slight inward rectiﬁcation with a reversal potential
close to 0 mV (Fig. 3F, black trace). Substitution of choline for
Na+ revealed a predominance of inward monovalent Na+ current
(Fig. 3F, green andmagenta traces). However, unlikeG98DOrai1,
Ca2+ ions blocked theG98P channels; in the presence of choline as
the major cation, reduction of Ca2+ from 2 to 0.2 mM increased
both inward and outward currents (Fig. 3 E and F, gold trace).
Changing external [Ca2+]o from 2 to 20 mM slightly increased the
inward current for G98P, suggesting that the G98P channel does
conduct Ca2+ to a limited extent, but less than in G98D (data
summary in Fig. S5). Similar to G98DOrai1, 10 μMGd3+ potently
and reversibly blocked the G98P current (n= 3). In summary, our
analysis of ion selectivity indicates that proline or aspartate at
position 98 induces spontaneous Orai1 channel activity that is
nonselective for monovalent cations. Ca2+ is sparingly permeant in
G98D, but acts primarily to block monovalent currents in G98P.
Dominance of G98D. Orai1 double mutants were then generated to
address the question of whether a G98-activating mutation can
change the Orai1 channel phenotypes of R91W (nonconducting
channels) and R91C (diamide-induced disulﬁde bonds and chan-
nel block). In the double mutants R91W/G98D and R91C/G98D,
the presence of G98D appeared to dominate in eliciting large,
spontaneously active current with nearly linear I-V shapes and
modiﬁed ion selectivity. As in the G98D single mutant, STIM1
expression was not required for channel function. In the double
mutant R91W/G98D, we noted spontaneous current with similar,
although not identical, biophysical characteristics (Fig. 4 A and B),
compared with the single mutant G98D Orai1 (Fig. 3 C and D).
Again, substitution of Na+ by choline considerably reduced the
inward current amplitudes, indicating a predominantly Na+-se-
lective channel. The presence of signiﬁcant outward current indi-
cates that Cs+ is also permeant. However, for the R91W/G98D
double mutant, varying external Ca2+ concentration did not pro-
duce changes consistent with measurable Ca2+ permeability. The
contribution of Ca2+ ions was just 3 ± 1% of the total current,
compared with 7 ± 1% for G98D (Fig. S5). Our results indicate
that despite the presence of the bulky SCID-inducing tryptophan
at position 91, the presence of G98D restores channel activity,
albeit with reduced Ca2+ permeability. Next, we examined R91C/
G98D currents (Fig. 4 C and D). Again, double-mutant channels
were spontaneously active with fairly linear I-V characteristics, and
results from choline substitution indicated a predominance of Na+
inward current. Varying external Ca2+ concentration clearly pro-
duced changes in current consistent with a measurable contribu-
tion of Ca2+ current. Most importantly, R91C/G98D was not
efﬁciently blocked by diamide (Fig. 4 E and F); note that neither
diamide nor BMS had any detectable effect on R91C/G98D cur-
rent. These results indicate that the presence of G98D widens and
activates the pore to conduct with altered ion selectivity; more-
over, they reinforce the suggestion that the G98 sites of Orai1
may serve as gating hinges for channel opening and closing.
Discussion
In this study, we characterize a gain-of-function Orai1 mutation
(G98D) that spontaneously opens the channel and mediates Ca2+
entry without store release and without coexpression of STIM1 or
STIM1 fragments. Based on single-cell Ca2+-imaging and patch-
clamp data, we speculate that both G98D and G98P mutants are
locked in an open channel conformation, due to a structural
change in the middle of the Orai1 TM1 helix caused by aspartate
or proline substitution. This may result in the normal channel
“gate” near or at R91 being opened at the cytosolic (inner) end of
TM1. We further hypothesize that the original Gly residue at the
98 site serves functionally as a “gating hinge,” switching channel
conformations between the closed state and the open state.
Structural and functional evidence for gating hinges at trans-
membrane glycine residues has been reported previously in the
voltage gated-like channel superfamily that includes voltage-gated
K+, Na+, and Ca2+ channels (31–33). Moreover, substitutions of
aspartate or proline in transmembrane helices have been shown to
cause constitutive activation of voltage-gated channels (34, 35).
However, in these instances, ion selectivity does not change when
gating is perturbed, consistent with a rigid selectivity ﬁlter in the
voltage gated-like channels. The Orai channel family bears no
sequence or structural resemblance to these channels. However,
our results suggest that glycines in TM1 may play a key role in the
gating of the Orai1 channel and that ion selectivity is not rigidly
deﬁned as for voltage gated-like channels.
Fig. 4. Dominance of G98D mutation. (A) G98D restores channel activity of
R91W Orai1. Expression of R91W/G98D Orai1 results in preactivated cationic
current. (B) Corresponding I-V curves for conditions indicated in A. (C and D)
Properties of nonselective R91C/G98D Orai1 current: cationic permeability
(C) and corresponding I-V relationships (D). (E) Diamide application does not
suppress R91C/G98D current (n = 3 cells). (F) Corresponding I-V curves for the
time points indicated in E.
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Based on structural knowledge from potassium and sodium
channels (31, 36), our results and interpretations can be for-
mulated into a hypothetical gating mechanism (Fig. 5A). The
Orai channels are multitransmembrane proteins that form a tet-
rameric pore (18, 20, 29), and it is reasonable to propose that the
Orai1 channel has a very narrow part (gate) within its pore that
prevents ion conductance in the closed state. In the open state,
this very narrow part is pulled away by the surrounding α-helices.
The G98 sites are very likely to be responsible for this confor-
mational change upon channel activation. This is supported by
the fact that the G98 residue is the only one along the Orai1 TM1
fragment that provides relatively large ﬂexibility on the backbone
dihedral angles for conformational changes. A recent report also
suggested that the N-terminal half (inner side) of TM1 has ro-
tational mobility potential or ﬂexibility of the protein backbone
(27). Moreover, we show that alanine substitution inhibits chan-
nel activation, whereas more perturbing substitutions—aspartate
or proline—result in constitutive channel activation.
We also demonstrate that the R91 sites on adjacent Orai1
subunits can be cross-linked by oxidation of cysteines, allowing
the relative distance between R91 sites to be estimated func-
tionally by biochemical analysis and in real-time while Ca2+
imaging or during a patch-clamp experiment. The ability of
R91C Orai1 to form disulﬁde bonds between neighboring sub-
units, even in a cysteine-less background, clearly demonstrates
that this site forms a very narrow ring at the cytosolic side of the
channel. Our data suggest that during dynamic ﬂuctuation, the
adjacent thiol side chains from 91 sites could approach each
other. Moreover, they imply that bulky hydrophobic amino acid
substitutions, such as the R91W mutation in humans that causes
SCID, physically occlude the pore at the cytosolic side of the
channel (Fig. 5B). In other words, a greasy plug results in a dead
channel. The physical distance between the R91 side chains
within a WT Orai1 channel may be greater than in R91C, given
the electrostatic repulsion that would create. However, the
similarity in function of R91C Orai1 channels to WT indicates
that cysteine replacement at site 91 does not signiﬁcantly change
the overall structure and the gating mechanism of Orai1 chan-
nels. Two facts support the idea that Orai1 channels close their
inner gate in the resting state: R91C can be cross-linked by di-
amide, and R91G or R91A Orai1 channels with even shorter side
chains do not open spontaneously. These results suggest that
conformational changes on the cytosolic half of TM1 (below the
98 site) open the channel, the glycine hinge at site 98 providing
ﬂexibility to open the inner gate upon STIM1 interaction. Our
results and interpretations are consistent with previous reports
that bulky hydrophobic residues impair the gating of Orai1
channels but do not greatly perturb the dynamic coupling be-
tween STIM1 and R91W Orai1 (25, 37).
Turning to the control of ion selectivity in the Orai1 channel,
recent cysteine-scanning studies focusing on the TM1 region of
Orai1 support a predicted α-helical structure with three additional
sites (S88, L95, andV102) that may face the pore lumen (27, 28). A
tetrameric structure for the open channel with several rings
aligned from top to bottom forming a long and narrow conducting
pore may well explain the extremely low conductance (∼10 fS) of
native or expressed CRAC current. At the top of TM1, a con-
served glutamate residue (E106) is thought to determine Ca2+
selectivity because a relatively minor point mutation that shortens
the side chain by one carbon atom (E106D Orai1, or E180D in
Drosophila Orai) promotes nonselective cation permeability, in-
cluding Cs+ with a diameter of 3.3 Å (9–11). Because E106D
channels with a widened selectivity ﬁlter do not open spontane-
ously, we suggest that the opening of the G98D mutant channel is
associated with increased distance between TM1 helices, including
an enlarged opening at the cytosolic end of TM1. Pore dilation
from top to bottom would thus result in a nonselective and con-
stitutively active “leaky” channel associated with higher single-
channel conductance and reduced sensitivity to block by Gd3+
(Fig. 5C). This is further supported by the results from the double
mutants. R91W Orai1 does not normally conduct even when the
channels are in the open state and engaged by STIM1 after store
depletion (25, 37). The bulky hydrophobic side chains from the
tryptophan residues prevent Ca2+ inﬂux, permanently closing the
channels. G98D doublemutants are also spontaneously active, and
the fact that G98D can overcome the silent-channel phenotype of
R91W channels in the R91W/G98D double mutant further sug-
gests that the cytosolic side of TM1 is dilated by the G98D mu-
tation (Fig. 5D), leading to constitutively open and nonselective
channels. Furthermore, we showed that the R91C/G98D double
mutant forms a nonselective cation channel that is resistant to
diamide-induced block, again consistent with an overall dilation of
the open channel produced by G98D.
Fig. 5. Schematic models of Orai1/CRAC channel gating.
Two of the pore-lining Orai1 TM1 segments are shown,
with E106, G98, and R91 highlighted from outside to inside.
(A) E106 sites near the outside control Ca2+ selectivity. The
open pore has a diameter <3.3 Å, the diameter of an
impermeant Cs+ ion. Near the inside, the R91 sites prevent
ion ﬂow in the closed state of the channel. Located in the
middle of TM1, the G98 sites permit a conformational
change that opens the channel upon store depletion fol-
lowed by STIM1–Orai1 interaction. (B) R91W Orai1, irre-
versibly closed by a greasy tryptophan plug and hence
a “dead” channel. (C) Spontaneously open G98D Orai1,
with a dilated pore allowing nonselective currents (leaky)
to permeate. (D) G98D/R91W double mutant, spontane-
ously open and leaky, allowing monovalent cation perme-
ation despite tryptophan at position 91.
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Studies of STIM/Orai coupling have led to an increasingly
reductionist approach to understanding CRAC channel gating
(26). The ﬁeld has discovered progressively simpler ways to ac-
tivate CRAC currents from receptor-mediated intracellular sig-
naling pathways to ER Ca2+-store depletion itself as the
physiological activator, to point mutations of STIM proteins that
disable Ca2+ sensing, chemically induced oligomerization of
STIM, expression of cytosolic STIM fragments that activate Orai
channels, 2-APB as a ligand for Orai3 channel activation, and
now the identiﬁcation of Orai1 gain-of-function mutants with
altered gating and ion selectivity. We note that our results reveal
a third way to open the Orai1 channel, each resulting in a distinct
set of open channel characteristics. Activation of Orai1 by
STIM1 or the smaller activating fragments yields a low-conduc-
tance, Ca2+-selective pore with an inward rectifying I-V char-
acteristic (26). Activation by 2-APB of Orai3 and, to a lesser
extent, Orai1 yields a higher-conductance, nonselective cation
pore with a biphasic I-V (22, 38). In contrast, the two G98
mutants exhibit spontaneous activity of a high-conductance,
nonselective pore with a nearly linear I-V shape. These results
provide clues to the molecular mechanism of CRAC channels
and suggest directions for investigating the pathological roles of
CRAC channels by overexpression of gain-of-function Orai1
mutants in different cell types. The fact that the G98 mutants
reported here are single-point mutants further suggests the
possibility of naturally occurring gain-of-function mutations in
Orai1 with pathological consequences.
Materials and Methods
Cells. Human embryonic kidney (HEK)-293A cells obtained from Invitrogen
were maintained in Dulbecco’s modiﬁed Eagle medium (Lonza) supple-
mented with 10% fetal calf serum (Omega Scientiﬁc) and 2 mM L-glutamine
(Sigma). HEK-293A cells were transfected using Lipofectamine 2000 (Invi-
trogen) or GenJet Plus (SignaGen Laboratories) reagents and used after 24 h
for [Ca2+]i imaging, immunocytochemistry, or Western blotting, and after
48–72 h for patch-clamp electrophysiology.
Molecular Cloning and Mutagenesis. The generation of pcDNA3/humanSTIM1
and pcDNA5/Myc-humanOrai1 and eGFP-tagged humanOrai1 was described
previously (6, 22, 39). All Orai1 mutants were created by exchanging the
corresponding codons using the QuikChange Site-Directed Mutagenesis Kit
(Stratagene). Information on primer design and conditions for cloning and
PCR is available upon request.
Single-Cell [Ca2+]i Imaging. Ratiometric [Ca
2+]i imaging was performed as de-
scribed (22). Transfected cells were identiﬁed by the coexpressed GFP using
ﬁlters to avoid contamination of fura-2 ﬂuorescence by bleed-through of GFP
ﬂuorescence. Data were analyzed with Metaﬂuor software (Universal Imag-
ing) and OriginPro 7.5 software (OriginLab) and are expressed as means ± SE.
Diamide Assays. Two days after transfection, six-well dishes plated with HEK-
293A cells were washed and then bathed in 2 mM Ca Ringer solution with or
without diamide (10 mM ﬁnal concentration) at room temperature for 30
min, followed by N-ethylmaleimide quenching (50mMﬁnal concentration) at
room temperature for 15min. Cells were thenwashedwith cold PBS and lysed
in 300 μL of RIPA lysis buffer (Upstate) supplemented with 1× Complete
EDTA-free protease inhibitor mixture (Roche Applied Science) and passed
ﬁve times through a 26-gauge needle.
Whole-Cell Recording. Whole-cell recordings were done on transfected HEK-
293A cells as described previously (11, 22), using procedures and solutions
(Table S1) described in SI Materials and Methods.
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